norelgestromin has been researched along with norgestrel in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.45) | 18.7374 |
| 1990's | 3 (4.35) | 18.2507 |
| 2000's | 55 (79.71) | 29.6817 |
| 2010's | 10 (14.49) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flor, S; Hahn, DW; Kafrissen, ME; McGuire, JL; Phillips, A; Tolman, EL | 1 |
| Dai, MZ; Li, LZ; Liu, CQ; Liu, GM; Shen, SR; Zhu, JY | 1 |
| Fritzemeier, KH; Hegele-Hartung, C; Krattenmacher, R; Kuhnz, W | 1 |
| Duda, M; Edom, RW; Huang, M; Juzwin, S; Tegegne, G; Tischio, JP; Wong, FA | 1 |
| Abrams, LS; Anderson, NJ; Leese, PT; Skee, DM; Wong, FA | 1 |
| Creasy, GW; Fisher, AC; Lenihan, JP; Meador, ML; Shangold, GA; Smallwood, GH | 1 |
| Abrams, LS; Creasy, GW; Fisher, AC | 1 |
| Abrams, LS; Creasy, GW; Leese, PT; Natarajan, J; Shangold, MM; Skee, DM; Wong, FA | 1 |
| Abrams, LS; Lasseter, KC; Natarajan, J; Skee, DM; Wong, FA | 1 |
| Zieman, M | 1 |
| Abrams, LS; Natarajan, J; Skee, D; Wong, FA | 1 |
| Creasy, GW; Fisher, AC; Guillebaud, J; Shangold, GA; Weisberg, E; Zieman, M | 1 |
| Creasy, GW; Fisher, AC; Meador, ML; Odlind, V; Shangold, GA; Sibai, BM | 1 |
| Archer, DF; Bigrigg, A; Creasy, GW; Fisher, AC; Shangold, GA; Smallwood, GH | 1 |
| Creasy, GW; Fisher, AC; Hedon, B; Mansour, D; Shangold, GA; Zacur, HA | 1 |
| Abrams, LS; Anderson, GD; Natarajan, J; Skee, DM; Wong, FA | 1 |
| Abrams, LS; Allen, JG; Creasy, GW; Hammond, GL; Natarajan, J; Siiteri, PK | 1 |
| Sicat, BL | 1 |
| Creasy, GW; Fisher, AC; Hall, N; Shangold, GA | 1 |
| Caubel, P; Chetrite, GS; Friedman, AJ; Pasqualini, JR; Philippe, JC | 1 |
| Archer, DF; Creasy, GW; Fisher, AC; Moreau, M; Pierson, RA; Shangold, GA | 1 |
| Hussar, D | 1 |
| Henzl, MR; Loomba, PK | 1 |
| Fanta, M | 1 |
| Evans, SL; Forinash, AB | 1 |
| Gaspard, U | 1 |
| Halpern-Felsher, BL; Irwin, CE; Rubinstein, ML | 1 |
| Lelle, I; Prifti, S; Rabe, T; Strowitzki, T; Zhong, G | 1 |
| Logsdon, S; Omar, HA; Richards, J | 1 |
| Dikov, I; Ivanov, S; Sigridov, I | 1 |
| Lidegaard, O | 1 |
| Levine, JP | 1 |
| Lelle, I; Prifti, S; Rabe, T; Strowitzki, T | 1 |
| Abramowitz, W; Jakate, AS; Kapil, R; Patel, A; Persiani, S; Roy, P; Wangsa, J | 1 |
| Dunn, K; Flanagan, P; Harel, D; Harel, Z; Riggs, S; Vaz, R | 1 |
| Fisher, AC; Friedman, AJ; Karvois, DL; Kaunitz, AM; Laguardia, KD; Stewart, FH | 1 |
| Audet, MC; Bouchard, C; Dattani, D; Dinniwell, J; Horbay, GL; Mawdsley, S; Moreau, M; Weisberg, F | 1 |
| Bainbridge, JD; Fisher, AC; Friedman, AJ; LaGuardia, KD; LoCoco, JM | 1 |
| Easthope, SE; Goa, KL; Warner, GT | 1 |
| Jain, JK; Stanczyk, FZ; White, T | 1 |
| Wooltorton, E | 1 |
| Atreja, A; Falcone, T; Harris, CM; Jain, A; Thacker, HL | 1 |
| Radowicki, S; Skórzewska, K; Szlendak, K | 1 |
| Szarewski, A | 1 |
| LaGuardia, KD | 1 |
| Devineni, D; Janssens, L; LaGuardia, KD; Leung, AT; Massarella, J; Skee, D; Vaccaro, N | 1 |
| Bacquet, A; Balaguer, P; Paris, F; Rabeolina, F; Sultan, C | 1 |
| Taneepanichskul, S | 1 |
| Suwanmalee, O; Taneepanichskul, S | 1 |
| Bobrowska, K; Durlik, M; Jabiry-Zieniewicz, Z; Kaminski, P; Pazik, J; Pietrzak, B; Wielgos, M | 1 |
| Badger, GJ; Cushman, M; Johnson, JV; Lowell, J; Rosing, J; Tchaikovski, S | 1 |
| Piyasirisilp, R; Taneepanichskul, S | 1 |
| Bruni, V; Crosignani, P; Marelli, S; Nappi, C; Piccoli, A; Ronsini, S | 1 |
| Dunbar, S; Johnson-Levonas, AO; Lasseter, KC; Li, S; Miller, DL; Rosko, K; Schwartz, JI; Wagner, JA; Yuan, J | 1 |
| Ding, C; Ge, Q; Liu, X; Zhi, X; Zhou, Z | 1 |
| Bruni, V; Crosignani, PG; Marelli, S; Nappi, C; Ronsini, S; Sonnino, D | 1 |
| Bifulco, G; Di Carlo, C; Formisano, C; Gargano, V; Massaro, M; Nappi, C | 1 |
| Aweeka, F; Cohn, SE; Kamemoto, L; Klingman, KL; Park, JG; Patterson, K; Vogler, MA; Watts, H | 1 |
| Foldemo, A; Josefsson, A; Lindberg, M; Wiréhn, AB | 1 |
| Kallio, S; Piltonen, T; Puurunen, J; Ruokonen, A; Tapanainen, JS; Vaskivuo, T | 1 |
| Cogque-Hernandez, G; Garcia-Latorre, EA; Hernandez-Giron, X; Hernandez-Juarez, J; Isordia-Salas, I; Julián-Nacer, R; Majluf-Cruz, A; Moran-Perez, JF; Moreno-Hernandez, M; Palafox-Gomez, R; Rodriguez-Escobedo, MA | 1 |
| Borland, J; Chen, S; Peppercorn, AF; Piscitelli, SC; Song, IH; Wajima, T | 1 |
| Archer, DF; Sriprasert, I; Stanczyk, FZ | 1 |
| Abdallah, IA; Hammell, DC; Hassan, HE; Stinchcomb, AL | 1 |
| Lavelanet, AF; Rybin, D; White, KO | 1 |
| Kam, J; Leahy, M; Meka, V; Nestorov, I; Sheikh, SI; Zhao, G; Zhu, B | 1 |
14 review(s) available for norelgestromin and norgestrel
| Article | Year |
|---|---|
Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites.
Topics: Animals; Biotransformation; Contraceptives, Oral; Drug Combinations; Female; Humans; Levonorgestrel; Molecular Structure; Norgestrel; Oximes | 1990 |
Transdermal contraception.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Drug Implants; Drug Interactions; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Pregnancy; Safety | 2001 |
Pharmacokinetic overview of Ortho Evra/Evra.
Topics: Administration, Cutaneous; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Half-Life; Humans; Norgestrel; Oximes | 2002 |
Ortho Evra, a new contraceptive patch.
Topics: Administration, Cutaneous; Animals; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethisterone; Female; Humans; Norgestrel; Oximes | 2003 |
Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Topics: Administration, Cutaneous; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Drug Delivery Systems; Equipment Design; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Ethisterone; Female; Gonadal Steroid Hormones; Humans; Male; Norgestrel; Oximes; Testosterone | 2003 |
[A transdermal form of combined hormonal contraceptives (EVRA)].
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes | 2003 |
New hormonal contraceptives: a comprehensive review of the literature.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Interactions; Estradiol; Ethinyl Estradiol; Ethisterone; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norgestrel; Oximes | 2003 |
Evra--a patch on oral contraception?
Topics: Administration, Cutaneous; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Patient Compliance; Pregnancy; Randomized Controlled Trials as Topic | 2003 |
[Medication of the month. Evra: first contraceptive transdermal patch].
Topics: Administration, Cutaneous; Adult; Contraception; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethisterone; Female; Glucose; Humans; Lipid Metabolism; Menstrual Cycle; Nausea; Norgestrel; Oximes; Vomiting | 2003 |
[Transdermal contraception--a new beginning].
Topics: Administration, Cutaneous; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Skin Absorption | 2004 |
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Topics: Affect; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Drug Combinations; Drug Implants; Ethisterone; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel; Oximes; Patient Education as Topic; Progesterone Congeners; Risk Factors; United States; Weight Gain; Women's Health | 2004 |
Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes | 2003 |
Hormonal contraception: recent advances.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health | 2006 |
Norelgestromin/ethinyl estradiol transdermal system.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes | 2005 |
29 trial(s) available for norelgestromin and norgestrel
| Article | Year |
|---|---|
Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches.
Topics: Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Time Factors | 2001 |
Efficacy and safety of a transdermal contraceptive system.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Pregnancy | 2001 |
Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise.
Topics: Adhesiveness; Administration, Cutaneous; Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Exercise; Female; Hot Temperature; Humans; Humidity; Middle Aged; Norgestrel; Oximes | 2001 |
Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Contraceptive Agents, Female; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Oximes; Time Factors | 2001 |
Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data.
Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Humans; Menstrual Cycle; Norgestrel; Oximes; Pregnancy; Proportional Hazards Models | 2002 |
Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women.
Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Humans; Middle Aged; Norgestrel; North America; Oximes; Patient Compliance | 2002 |
Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites.
Topics: Administration, Cutaneous; Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Female; Humans; Middle Aged; Norgestrel; Oximes | 2002 |
Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
Topics: Administration, Cutaneous; Adolescent; Adult; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Menstrual Cycle; Middle Aged; Norgestrel; Oximes; Reference Values; Time Factors; Triglycerides | 2003 |
Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medication Errors; Norgestrel; Ovarian Follicle; Ovulation; Oximes; Progesterone; Ultrasonography | 2003 |
An evaluation of the use of the transdermal contraceptive patch in adolescents.
Topics: Administration, Cutaneous; Adolescent; Analysis of Variance; Contraceptives, Oral, Combined; Drug Combinations; Ethisterone; Female; Humans; Longitudinal Studies; Norgestrel; Oximes; Patient Compliance; Patient Satisfaction; San Francisco | 2004 |
Long-term evaluation of the use of the transdermal contraceptive patch in adolescents.
Topics: Administration, Cutaneous; Adolescent; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethisterone; Female; Humans; Norgestrel; Oximes; Patient Compliance; Time | 2004 |
Effect of multiple-dose dexloxiglumide on the pharmacokinetics of oral contraceptives in healthy women.
Topics: Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Norgestrel; Oximes; Pentanoic Acids; Receptors, Cholecystokinin | 2005 |
Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Menstruation; Middle Aged; Norgestrel; Oximes; Patient Satisfaction | 2005 |
Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study.
Topics: Administration, Cutaneous; Adolescent; Adult; Cohort Studies; Condoms; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Intrauterine Devices; Middle Aged; Norgestrel; Oximes; Patient Compliance; Patient Satisfaction; Safety; Spermatocidal Agents; Treatment Outcome | 2005 |
Suppression of estrogen-withdrawal headache with extended transdermal contraception.
Topics: Administration, Cutaneous; Adolescent; Adult; Delayed-Action Preparations; Drug Combinations; Ethisterone; Female; Headache; Humans; Middle Aged; Norgestrel; Oximes; Substance Withdrawal Syndrome; Time Factors | 2005 |
Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
Topics: Administration, Cutaneous; Adolescent; Adult; Androgens; Androstenedione; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2005 |
[Safety evaluation of a transdermal contraceptive system with an oral contraceptive].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Women's Health | 2005 |
Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
Topics: Abdomen; Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Buttocks; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Female; Half-Life; Humans; Middle Aged; Norgestrel; Oximes | 2007 |
Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Antithrombins; Blood Coagulation; Blood Proteins; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Factor VIII; Female; Fibrinogen; Humans; Norgestrel; Oximes; Protein S; Risk Factors; Thrombosis; von Willebrand Factor | 2008 |
A clinical study of transdermal contraceptive patch in Thai adolescence women.
Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Blood Pressure; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Dysmenorrhea; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Oximes; Thailand | 2008 |
Effect of the ethinylestradiol/norelgestromin contraceptive patch on body composition. Results of bioelectrical impedance analysis in a population of Italian women.
Topics: Administration, Cutaneous; Adolescent; Adult; Body Composition; Body Mass Index; Body Water; Contraceptives, Oral, Combined; Drug Combinations; Electric Impedance; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Oximes; Weight Gain; Young Adult | 2008 |
Influence of taranabant, an orally active, highly selective, potent cannabinoid-1 receptor (CB1R) inverse agonist, on ethinyl estradiol and norelgestromin plasma pharmacokinetics.
Topics: Administration, Oral; Adult; Amides; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Inverse Agonism; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes; Pyridines; Receptor, Cannabinoid, CB1; Young Adult | 2009 |
Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Italy; Middle Aged; Norgestrel; Oximes; Patient Compliance; Patient Satisfaction; Pregnancy; Quality of Life; Treatment Outcome; Young Adult | 2009 |
Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
Topics: Absorptiometry, Photon; Amino Acids; Analysis of Variance; Bone and Bones; Bone Density; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes; Prospective Studies | 2010 |
Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Estrogens; Ethinyl Estradiol; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Middle Aged; Norgestrel; Oximes; Pyrimidinones; Ritonavir; Transdermal Patch; United States | 2010 |
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.
Topics: Administration, Cutaneous; Adult; Anti-Mullerian Hormone; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone, Human; Humans; Norgestrel; Ovarian Follicle; Oximes; Pituitary Gland; Prospective Studies; Young Adult | 2013 |
Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol.
Topics: Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Heterocyclic Compounds, 3-Ring; HIV Integrase Inhibitors; Humans; Luteinizing Hormone; Norgestrel; Oxazines; Oximes; Piperazines; Progesterone; Pyridones | 2015 |
Evaluation of Potential Drug-Drug Interaction Between Delayed-Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Healthy Women.
Topics: Administration, Oral; Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Delayed-Action Preparations; Dimethyl Fumarate; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Fumarates; Humans; Immunosuppressive Agents; Maleates; Norgestrel; Oximes; Young Adult | 2017 |
26 other study(ies) available for norelgestromin and norgestrel
| Article | Year |
|---|---|
[A comparative study on the antifertility action of levonorgestrel oxime and levonorgestrel].
Topics: Animals; Contraceptive Agents, Female; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Drug Combinations; Embryo Implantation; Endometrium; Female; Levonorgestrel; Norgestrel; Oximes; Pregnancy; Rats; Rats, Inbred Strains; Stereoisomerism | 1988 |
Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor.
Topics: Animals; Drug Combinations; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Pregnancy; Pregnancy Maintenance; Progesterone; Rabbits; Rats; Rats, Wistar; Receptors, Progesterone | 1995 |
Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Stability; Female; Humans; Levonorgestrel; Mass Spectrometry; Molecular Structure; Norgestrel; Oximes; Quality Control; Reproducibility of Results; Sensitivity and Specificity | 1999 |
The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
Topics: Administration, Cutaneous; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Progestins | 2002 |
A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Ethisterone; Female; Humans; Middle Aged; Norgestrel; Oximes; Pregnancy | 2002 |
Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions.
Topics: Adhesives; Administration, Cutaneous; Adolescent; Adult; Climate; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Exercise; Female; Hot Temperature; Humans; Humidity; Middle Aged; Norgestrel; Oximes | 2002 |
Ortho Evra--a contraceptive patch.
Topics: Contraceptive Agents; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Oximes | 2002 |
Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. Effect on sulfatase activity in comparison to medroxyprogesterone acetate.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethisterone; Humans; Inhibitory Concentration 50; Medroxyprogesterone Acetate; Models, Chemical; Norgestrel; Oximes; Selective Estrogen Receptor Modulators; Sulfatases; Tumor Cells, Cultured | 2003 |
New drugs 2003, part II.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Approval; Drug Combinations; Drug Therapy; Epoprostenol; Estradiol; Ethisterone; Filgrastim; Fondaparinux; Fulvestrant; Granulocyte Colony-Stimulating Factor; Humans; Norgestrel; Oximes; Polyethylene Glycols; Polysaccharides; Recombinant Proteins; Triptorelin Pamoate; United States; Vinyl Compounds | 2003 |
New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra).
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Device Approval; Drug Combinations; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; United Kingdom; Women's Health | 2004 |
Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin.
Topics: 17-alpha-Hydroxyprogesterone; Cell Line, Tumor; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Ethisterone; Female; Humans; Matrix Metalloproteinase 2; Norgestrel; Oximes; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2004 |
[Hormonal contraceptive patch].
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Risk Factors | 2004 |
Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Contraceptives, Oral, Combined; Dihydrotestosterone; Drug Combinations; Ethisterone; Genetic Vectors; Humans; Luciferases; Norgestrel; Oximes; Receptors, Androgen; Testosterone; Transfection; Tumor Cells, Cultured | 2004 |
Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
Topics: Abdomen; Acne Vulgaris; Administration, Cutaneous; Adolescent; Attitude to Health; Breast; Buttocks; Condoms; Contraceptives, Oral, Combined; Drug Carriers; Drug Combinations; Dysmenorrhea; Ethisterone; Female; Headache; Humans; Menstrual Cycle; Menstruation; Nausea; Norgestrel; Oximes; Patient Dropouts; Patient Satisfaction | 2005 |
The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.
Topics: Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; United States; United States Food and Drug Administration | 2006 |
How should we advise patients about the contraceptive patch, given the FDA warning?
Topics: Contraceptives, Oral, Combined; Counseling; Drug Combinations; Drug Utilization; Ethisterone; Female; Humans; Norgestrel; Oximes; Physician-Patient Relations; Practice Patterns, Physicians'; Risk Assessment; United States; United States Food and Drug Administration; Venous Thrombosis | 2006 |
Performance of contraceptive patch compared with oral contraceptive pill in a high-risk population.
Topics: Administration, Cutaneous; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes | 2006 |
Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Animals; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levonorgestrel; Norgestrel; Oximes; Protein Binding; Receptors, Androgen; Time Factors; Transfection | 2007 |
A clinical study of transdermal contraceptive patch in Thai women.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Agents; Drug Combinations; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Oximes; Patient Compliance; Patient Satisfaction; Prospective Studies; Thailand | 2006 |
Oral and transdermal hormonal contraception in women after kidney transplantation.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Bilirubin; Contraceptive Agents, Female; Creatinine; Delayed-Action Preparations; Drug Combinations; Ethinyl Estradiol; Female; Fertility; Hematocrit; Humans; Kidney Transplantation; Norgestrel; Oximes | 2007 |
Determination of norelgestromin in rabbit plasma by LC-MS/MS and its application to the pharmacokinetic study of ORTHO EVRA.
Topics: Animals; Chromatography, Liquid; Contraceptives, Oral, Combined; Drug Combinations; Drug Stability; Ethinyl Estradiol; Female; Linear Models; Norgestrel; Oximes; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2009 |
Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
Topics: Adolescent; Adult; Age Distribution; Antidepressive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Drug Utilization; Female; Humans; Levonorgestrel; Logistic Models; Lynestrenol; Medroxyprogesterone; Norgestrel; Odds Ratio; Oximes; Population Surveillance; Practice Patterns, Physicians'; Registries; Sweden | 2012 |
Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.
Topics: Adiponectin; Adult; C-Peptide; C-Reactive Protein; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Lipid Metabolism; Liver Function Tests; Longitudinal Studies; Mexico; Norgestrel; Oximes; Thyroid Function Tests; Transdermal Patch; Weight Gain | 2014 |
Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system.
Topics: Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Humans; Levonorgestrel; Norgestrel; Oximes | 2015 |
Norelgestromin/ethinyl estradiol intravenous infusion formulation optimization, stability and compatibility testing: A case study to overcome polysorbate 80 interference in chromatographic analysis.
Topics: Chromatography, High Pressure Liquid; Drug Combinations; Ethinyl Estradiol; Infusions, Intravenous; Limit of Detection; Norgestrel; Oximes; Reproducibility of Results | 2016 |
The pharmacokinetics of 12-week continuous contraceptive patch use.
Topics: Administration, Cutaneous; Adult; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes; Time Factors; Young Adult | 2017 |